AIM ImmunoTech Inc. (AIM)
NYSEAMERICAN: AIM · Real-Time Price · USD
1.390
-0.160 (-10.32%)
At close: Dec 2, 2025, 4:00 PM EST
1.390
0.00 (0.00%)
After-hours: Dec 2, 2025, 4:10 PM EST

AIM ImmunoTech Market Cap

AIM ImmunoTech has a market cap or net worth of $3.97 million as of December 2, 2025. Its market cap has decreased by -71.26% in one year.

Market Cap
3.97M
Enterprise Value
3.99M
1-Year Change
-71.26%
Ranking
n/a
Category
Stock Price
$1.39

Market Cap Chart

Since December 1, 1998, AIM ImmunoTech's market cap has decreased from $159.10M to $3.97M, a decrease of -97.51%. That is a compound annual growth rate of -12.77%.

History

DateMarket Cap% Change
Dec 1, 20254.40M-65.08%
Dec 31, 202412.60M-41.40%
Dec 29, 202321.50M43.33%
Dec 30, 202215.00M-65.91%
Dec 31, 202144.00M-39.56%
Dec 31, 202072.80M1,517.78%
Dec 31, 20194.50M-48.28%
Dec 31, 20188.70M-20.91%
Dec 29, 201711.00M-33.73%
Dec 30, 201616.60M-16.58%
Dec 31, 201519.90M-60.20%
Dec 31, 201450.00M12.61%
Dec 31, 201344.40M17.15%
Dec 31, 201237.90M43.02%
Dec 30, 201126.50M-60.27%
Dec 31, 201066.70M-10.23%
Dec 31, 200974.30M166.31%
Dec 31, 200827.90M-50.09%
Dec 31, 200755.90M-60.04%
Dec 29, 2006139.90M19.27%
Dec 30, 2005117.30M24.79%
Dec 31, 200494.00M10.33%
Dec 31, 200385.20M24.56%
Dec 31, 200268.40M-50.18%
Dec 31, 2001137.30M-2.21%
View and export this data all the way back to 1998. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

CompanyMarket Cap
Eli Lilly and Company962.96B
Johnson & Johnson498.53B
AbbVie402.43B
UnitedHealth Group298.72B
AstraZeneca286.85B
Merck & Co.260.19B
Novartis AG249.40B
Abbott Laboratories224.14B
Market Cap Rankings